ELOVL7

Across TCGA pan-cancer cohorts, ELOVL7 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of ELOVL7’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where ELOVL7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ELOVL7 is over-expressed in tumor, although a few such as BRCA show the opposite, repressed pattern.

KIRC, STAD, and HNSC are the cancer types where ELOVL7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ELOVL7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	All	+0.798	<.001	10	view →
STAD	All	III,IV	+1.677	<.001	9	view →
HNSC	Male	All	+0.691	.001	8	view →
KIRP	All	III,IV	+0.917	<.001	7	view →
BLCA	All	All	+0.896	.007	6	view →
LIHC	All	All	+0.824	.001	4	view →
BRCA	Female	II,III,IV	−0.602	<.001	4	view →
CHOL	Female	All	+4.930	<.001	3	view →
ESCA	All	All	+1.238	<.001	3	view →
PRAD	All	All	+1.129	<.001	2	view →
KICH	Female	All	+1.098	.005	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

ELOVL7–KIRC

Open the KIRC breakdown →